Barclays Boosts Veeva Systems (NYSE:VEEV) Price Target to $315.00

Veeva Systems (NYSE:VEEV) had its price objective lifted by Barclays from $275.00 to $315.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the technology company’s stock. Barclays‘s price target suggests a potential upside of 10.53% from the stock’s previous close.

A number of other research firms also recently weighed in on VEEV. Robert W. Baird lifted their price target on shares of Veeva Systems from $250.00 to $260.00 and gave the stock an “outperform” rating in a research note on Thursday, June 4th. Needham & Company LLC set a $310.00 price objective on shares of Veeva Systems in a research note on Thursday. Weiss Ratings raised shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 12th. BMO Capital Markets decreased their target price on shares of Veeva Systems from $220.00 to $175.00 and set a “market perform” rating on the stock in a research report on Thursday, June 4th. Finally, Raymond James Financial reissued an “outperform” rating and issued a $225.00 target price on shares of Veeva Systems in a research note on Thursday, June 4th. Nineteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Veeva Systems currently has a consensus rating of “Moderate Buy” and an average price target of $272.96.

Veeva Systems Price Performance

VEEV stock traded up $40.07 on Thursday, reaching $284.98. 2,666,684 shares of the company were exchanged, compared to its average volume of 2,455,288. The firm has a market capitalization of $46.29 billion, a PE ratio of 50.75, a PEG ratio of 1.06 and a beta of 0.92. Veeva Systems has a 12 month low of $148.05 and a 12 month high of $310.50. The stock’s fifty day moving average price is $203.41 and its 200 day moving average price is $183.04.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 EPS for the quarter, beating the consensus estimate of $2.22 by $0.13. The firm had revenue of $927.96 million during the quarter, compared to analysts’ expectations of $905.38 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. As a group, research analysts expect that Veeva Systems will post 6.65 EPS for the current fiscal year.

Insider Transactions at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of Veeva Systems stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the completion of the transaction, the insider directly owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.

Institutional Trading of Veeva Systems

Several large investors have recently added to or reduced their stakes in VEEV. Empire Life Investments Inc. raised its position in shares of Veeva Systems by 21.1% in the 4th quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock valued at $8,272,000 after acquiring an additional 6,453 shares during the period. Czech National Bank acquired a new position in Veeva Systems during the second quarter valued at approximately $7,584,000. BNP Paribas increased its stake in Veeva Systems by 89.3% in the fourth quarter. BNP Paribas now owns 19,239 shares of the technology company’s stock valued at $4,308,000 after purchasing an additional 9,077 shares in the last quarter. ABN Amro Investment Solutions increased its stake in Veeva Systems by 28.4% in the fourth quarter. ABN Amro Investment Solutions now owns 76,809 shares of the technology company’s stock valued at $17,146,000 after purchasing an additional 17,007 shares in the last quarter. Finally, AustralianSuper Pty Ltd acquired a new stake in Veeva Systems in the fourth quarter worth $2,453,000. 88.20% of the stock is owned by institutional investors.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Fiscal Q2 revenue rose 17.6% year over year to approximately $928 million, exceeding the $905 million consensus estimate. Adjusted earnings of $2.35 per share also beat expectations of $2.22 and increased from $1.99 a year earlier. Veeva Announces Fiscal 2027 Second Quarter Results
• Positive Sentiment: Management issued fiscal Q3 revenue guidance of $932 million to $935 million and EPS guidance of $2.33 to $2.34, both above Wall Street estimates. Full-year fiscal 2027 EPS guidance of $9.21 also topped the $8.58 consensus, while revenue guidance was raised above expectations.
• Positive Sentiment: AI momentum and strong customer adoption supported the outlook. Veeva reported record CRM performance, said Vault CRM maintains more than 70% market share, and expects its first Veeva Falcon AI deployments to go live this year. Veeva Q2 Earnings Call Highlights
• Positive Sentiment: Several firms raised their targets following the report: RBC increased its target to $325 and retained an “outperform” rating; Guggenheim raised its target to $310 with a “buy” rating; and Truist lifted its target to $305, also maintaining a “buy” rating. These revisions helped validate the bullish market reaction.
• Neutral Sentiment: UBS raised its target substantially to $290 but kept a “neutral” rating, indicating that the firm sees limited additional upside after the recent rally. Benzinga analyst coverage
• Negative Sentiment: Morgan Stanley increased its target to $275 but maintained an “equal weight” rating, placing its valuation below the current trading level and highlighting potential near-term valuation risk. Morgan Stanley price-target update

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.